DUBLIN--(BUSINESS WIRE)--The "Antiviral Drug Resistance Market to 2027 - Global Analysis and Forecasts by Product, Disease Indication, Technology, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
The global antiviral drug resistance market is expected to reach US$ 4,573.24 Mn in 2027 from US$ 2,572.26 Mn in 2018. The Antiviral drug resistance market is estimated to grow with a CAGR of 6.8% from 2019-2027.
The market is driven by factors such as, rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. However, the availability of alternative approaches may limit the growth of the market to a certain extent.
Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.
In spite of stringent quality control measures and advanced tools, a limited number of antiviral drugs are getting approved for human use. The mechanism of action of the antiviral drugs can differ, strengthening the immune response to the viral infection and ranging from targeting viral proteins to cellular proteins. Apart from antiviral drugs, some alternative approaches are used for the treatment of viral diseases.
These approaches include antisense oligonucleotides, aptamers, immunomodulators, vaccines, and ribozymes. The antisense nucleotide method comprises targeting specific nucleotides rather than proteins. Besides, oligonucleic acid or peptide molecules that bind to a particular target molecule is known as Aptamer. The peptide aptamers are used to treat viral infections. The peptide aptamers are designed to restrict other protein interactions inside the cells.
Global antiviral drug resistance were segmented by product, disease indication, technology, and end user. The product segment was categorized as kits & reagents and instruments. On the basis of the disease indication, the market is segmented as Human Immunodeficiency Virus [HIV], Hepatitis and Cytomegalovirus [CMV].
Similarly, based on technology, the market is fragmented as, immunodiagnostics, polymerase chain reaction [PCR], next generation sequencing [NGS], and other technologies. Based on end user, the antiviral drug resistance market is categorized as, hospitals & clinics, pathology or diagnostic laboratories and research institutes.
Some of the major primary and secondary sources included in the report include, National Cancer Institute, National AIDS Research Institute, International Diabetes Federation, Centers for Disease Control and Prevention, and Food and Drug Administration, among others.
Key Topics Covered
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Antiviral Drug Resistance Market - By Product
1.3.2 Global Antiviral Drug Resistance Market - By Disease Indication
1.3.3 Global Antiviral Drug Resistance Market - By Technology
1.3.4 Global Antiviral Drug Resistance Market - By End User
1.3.5 Global Antiviral Drug Resistance Market - By Geography
2. Global Antiviral Drug Resistance Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antiviral Drug Resistance Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinion
4.4 Cost of Test, By Test Type
4.5 Test Volume, By Region
5. Global Antiviral Drug Resistance Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in the Incidences of Hepatitis Diseases
5.1.2 Increasing Prevalence of HIV/AIDS
5.2 Key Market Restraints
5.2.1 Alternative Approaches
5.3 Key Market Opportunities
5.3.1 Increasing Healthcare Expenditures in Emerging Markets
5.4 Future Trends
5.4.1 Demand For Higher Quality Products
5.5 Impact Analysis
6. Antiviral Drug Resistance Market - Global Analysis
6.1 Global Antiviral Drug Resistance Market Revenue Forecasts And Analysis
6.2 Global Antiviral Drug Resistance Market, By Geography - Forecasts And Analysis
6.3 Positioning of Key Players
7. Global Antiviral Drug Resistance Market Analysis - by Product
7.1 Overview
7.2 Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
7.3 Kits and Reagents
7.4 Instruments
8. Global Antiviral Drug Resistance Market Analysis - by Disease Indication
8.1 Overview
8.2 Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
8.3 HIV
8.4 Hepatitis
8.5 Cytomegalovirus (CMV)
9. Global Antiviral Drug Resistance Market Analysis - by Technology
9.1 Overview
9.2 Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
9.3 Immunodiagnostics
9.4 Polymerase Chain Reaction (PCR)
9.5 Next Generation Sequencing (NGS)
9.6 Other Technologies
10. Global Antiviral Drug Resistance Market Analysis - by End User
10.1 Overview
10.2 Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
10.3 Hospitals and Clinics
10.4 Pathology and Diagnostic Laboratories
10.5 Research Institutes
11. Antiviral Drug Resistance Market Revenue and Forecasts to 2027 - Geographical Analysis
11.1 North America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.2 Europe Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.3 Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027
11.4 Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts To 2027
11.5 South & Central America Antiviral Drug Resistance Market Revenue And Forecasts To 2027
12. Antiviral Drug Resistance Market - Industry Landscape
13. Antiviral Drug Resistance Market - Key Company Profiles
13.1 AccuBioTech Co. Ltd.
13.2 ACON Laboratories Inc.
13.3 Siemens AG
13.4 bioMerieux S.A.
13.5 Bio-Rad Laboratories Inc.
13.6 Danaher
13.7 Abbott
13.8 BD
13.9 F. Hoffmann-La Roche Ltd.
13.10 Trinity Biotech
For more information about this report visit https://www.researchandmarkets.com/r/ig9uog
